Citations

Showing 10 of 108135 citations.

Prevention of acute exacerbation of chronic obstructive pulmonary disease after bronchoscopic lung volume reduction with endobronchial valves
Lee‐Mateus, Alejandra Yu , Garcia‐Saucedo, Juan C. , Saifi, Omran , Patel, Neal M. , Herth, Felix , Woytanowski, J.R. , Alshelli, Ihab, Alevas, Sajive, Becerra, Juan Pablo Uribe, Majid, Adnan , Edell, Eric S. , Dulohery-Scrodin, Megan, Reisenauer, Janani , Jantz, Michael A., Abbas, Hawazin K., Fernández-Bussy, Sebastián , Yu Lee-Mateus, Alejandra, Dulohery-Scrodin, Megan M, Reisenauer, Janani S, Yu Lee-Mateus, Alejandra , Abia‐Trujillo, David , Mehta, Hiren J.

Mayo Clinic

The Clinical Respiratory Journal | October 5, 2021 | Volume: 16 | Issue: 1 | Pages: 43-48

10.1111/crj.13450 | PMID 34605606 Get It

AbstractIntroductionBronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBVs) has emerged as an important treatment method for patients with severe chronic obstructive pulmonary disease (COPD). Acute exacerbations of COPD (AECOPD) are a frequent complication following BLVR with EBV. However, there is no consensus on the prevention of AECOPD.ObjectivesOur study aims to compare the outcomes of different prophylactic measures on the occurrence of AECOPD after BLVR with EBV.MethodsWe conducted a multicenter, retrospective study of patients who underwent BLVR with EBV at six different institutions. Emphasis was directed towards the specific practices aimed at preventing AECOPD: antibiotics, steroids, antibiotics plus steroids, or no prophylaxis. Subgroups were compared, and odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated.ResultsA total of 170 patients were reviewed. The rate of AECOPD was 21.2% for the full cohort. Patients who received prophylaxis had a significantly lower rate of AECOPD compared with those who did not (16.7% vs. 46.2%; p = 0.001). The rate was lowest in patients who received antibiotics alone (9.2%). There was no significant difference in the rate of AECOPD between patients who received steroids alone or antibiotics plus steroids, compared with the other subgroups. The OR for AECOPD was 4.3 (95% CI: 1.8–10.4; p = 0.001) for patients not receiving prophylaxis and 3.9 (95% CI: 1.5–10.1; p = 0.004) for prophylaxis other than antibiotics alone.ConclusionsAdministration of antibiotics after BLVR with EBV was associated with a lower rate of AECOPD. This was not observed with the use of steroids or in combination with antibiotics.
V.I.T.A.M. in COVID 19: A Systematic Approach to a Global Pandemic
Yarrarapu, Siva Naga S. , Bansal, Pankaj , Cusick, Austin , Melody, Megan , Moktan, Varun , Rivero, Andrea , Brigham, Tara , Brumble, Lisa , OʼBrien, Jennifer , Lee, Augustine S. , Klaus, Torp, Santos, Christan D. , Rivera, Candido E., Siegel, Jason , Sanghavi, Devang , Brigham, Tara J, Jennifer, J O'brein, Lee, Augustine, Santos, Christan, Rivera, Candido, Brigham, T J , Bansal, Pankaj , Yarrarapu, Siva Naga S , Abia‐Trujillo, David , Rivero, Andrea, Libertin, Claudia R. , Guru, Pramod , Franco, Pablo Moreno

Mayo Clinic

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | October 5, 2021 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/11795484211047432 | PMID 34629922 Get It

Introduction In the unprecedented era of COVID-19, ongoing research and evolution of evidence has led to ever-changing guidelines for clinical monitoring and therapeutic options. Formulating treatment protocols requires the understanding and application of the evolving research. Objective The primary objective of this study is to present a systematic evidence-based approach to synthesize the necessary data in order to optimize the management of COVID-19. Methods At Mayo Clinic Florida, we developed a multidisciplinary centralized COVID Treatment Review Panel (TRP) of expert pulmonologists, intensivists, infectious disease specialists, anesthesiologists, hematologists, rheumatologists, and hospitalists that in real-time reviews the latest evidence in peer-reviewed journals, the available clinical trials, and help guide the rapid application of therapeutics or interventions to the patient and the bedside provider. Results/Conclusions The multi-disciplinary team approach of synthesizing clinical data and coordinating care is effective in responding to rapidly evolving and changing evidence. Systematic data collection and evidence-based treatment algorithms enable physicians to rapidly translate the current literature to clinical practice, and improve care and outcomes of patients.
Composite Anterolateral Thigh and Fascia Lata Free Flap for Abdominal and Groin Reconstruction in a Pediatric Patient
Teven, Chad M. , Lundberg, Jaclyn N., Mabee, Melinda K., Garvey, Erin M., Davenport, Katherine P., Schaub, Timothy A., Pflibsen, Lacey R. , Hammond, Jacob B.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | October 4, 2021 | Volume: 9 | Issue: 10 | Pages: e3837

10.1097/gox.0000000000003837 | PMID 34616640 Get It

Summary: Large abdominal wall and groin defects present complex reconstructive challenges. These defects typically require free flap reconstruction to bring in healthy vascularized tissue and recreate the complex full-thickness defect. A 6-year-old previously healthy girl presented to our trauma center after sustaining a close-range shotgun injury resulting in a full-thickness defect to the inferior hemi-abdomen and groin. A composite anterolateral thigh flap with fascia lata free flap was performed to reconstruct the myofascial, skin, and subcutaneous tissue of the abdomen and groin. We present the first composite anterolateral thigh flap with fascia lata for full-thickness abdominal wall and groin reconstruction in a pediatric patient.
Influence of Geopolitics on Severity and Outcome in COVID-19*
Bauer, Philippe R.

Mayo Clinic

Critical Care Medicine | October 4, 2021 | Volume: 50 | Issue: 4 | Pages: 700-702

10.1097/ccm.0000000000005325 | PMID 34605775 Get It

Cardiac Surgery in Women in the Current Era: What Are the Gaps in Care?
Cho, Leslie , Kibbe, Melina R. , Bakaeen, Faisal G. , Aggarwal, Niti R., Davis, Melinda B. , Karmalou, Tara, Lawton, Jennifer S. , Ouzounian, Maral , Preventza, Ourania , Russo, Andrea M. , Zwischenberger, Brittany A. , Shroyer, Annie-Laurie W , Shroyer, A. Laurie , Lindley, Kathryn J

Mayo Clinic

Circulation | October 4, 2021 | Volume: 144 | Issue: 14 | Pages: 1172-1185

10.1161/circulationaha.121.056025 | PMID 34606298 Get It

Cardiovascular disease remains the leading cause of morbidity and mortality for women in United States and worldwide. One in 3 women dies from cardiovascular disease, and 45% of women >20 years old have some form of CVD. Historically, women have had higher morbidity and mortality after cardiac surgery. Sex influences pathogenesis, pathophysiology, presentation, postoperative complications, surgical outcomes, and survival. This review summarizes current cardiovascular surgery outcomes as they pertain to women. Specifically, this article seeks to address whether sex disparities in research, surgical referral, and outcomes still exist and to provide strategies to close these gaps. In addition, with the growing population of women of reproductive age with cardiovascular disease and cardiovascular risk factors, indications for cardiac surgery arise in pregnant women. The current review will also address the unique issues associated with this special population.
Carcinosarcoma of the Ovary
Bolan, Candice W. , Alexander, Lauren F. , LeGout, Jordan D.

Mayo Clinic

No container title available | October 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1148/cases.20211939 Get It

Two Wrongs Do Not Always Make a Right
Perez-Downes, Julio , Goldschlager, Nora , Kusumoto, Fred

Mayo Clinic

JAMA Internal Medicine | October 4, 2021 | Volume: 181 | Issue: 12 | Pages: 1639

10.1001/jamainternmed.2021.4436 | PMID 34605848 Get It

Genome-Wide Association Study of Peripheral Artery Disease
Zuydam, Natalie R. van , Stiby, Alexander, Abdalla, Moustafa , Austin, Erin , McLachlan, Stela , Vlachopoulou, Efthymia, Ahlqvist, Emma , Liao, Chen Di , Sandholm, Niina , Robertson, Neil R., Rayner, Nigel W. , Lindholm, Eero , Sinisalo, Juha , Kallio, Milla , Weiss, Emily , Price, Jackie F. , Paterson, Andrew D. , Klein, Barbara E.K. , Palmer, Colin N.A. , Groop, Per‐Henrik , Groop, Leif , Morris, Andrew P. , Hopewell, Jemma C. , Colhoun, Helen M. , Grétarsdóttir, Sólveig , Þorsteinsdóttir, Unnur , Stefánsson, Kāri , Michael, Mark , Kanninen, Timo, Patrono, Carlo, Nuutila, Pirjo , McKeague, Paul, Steckel-Hamann, Birgit, Gan, Li‐Ming , Nogoceke, Everson, Jablonka, Bernd, Brosnan, Mary-Julia, van Zuydam, Natalie R , Ahlqvist, Emma , Di Liao, Chen , Sandholm, Niina , Forsblom, Carol , Rayner, N William , Lindholm, Eero , Sinisalo, Juha , Perola, Markus , Kallio, Milla , Weiss, Emily , Paterson, Andrew , Salomaa, Veikko , Palmer, Colin N A , McCarthy, Mark I , de Andrade, Mariza , Hopewell, Jemma C , Colhoun, Helen M , Kullo, Iftikhar J , Dahlström, Emma H. , Mahajan, Anubha , McCarthy, Mark I. , Andrade, Mariza de , Kullo, Iftikhar J. , Þorleifsson, Guðmar , Mark, Michael, Thorand, Barbara , Remuzzi, Giuseppe , Dunger, David B. , Shore, Angela C. , Smith, Ulf , Ylä-Herttuala, Seppo , Cobelli, Claudio , Bellazzi, Riccardo , Ferrannini, Ele , Patrono, Carlo, Tortoli, Piero

Mayo Clinic

Circulation: Genomic and Precision Medicine | October 4, 2021 | Volume: 14 | Issue: 5 | Pages: No page available

10.1161/circgen.119.002862 | PMID 34601942 Get It

Background: Peripheral artery disease (PAD) affects >200 million people worldwide and is associated with high mortality and morbidity. We sought to identify genomic variants associated with PAD overall and in the contexts of diabetes and smoking status. Methods: We identified genetic variants associated with PAD and then meta-analyzed with published summary statistics from the Million Veterans Program and UK Biobank to replicate their findings. Next, we ran stratified genome-wide association analysis in ever smokers, never smokers, individuals with diabetes, and individuals with no history of diabetes and corresponding interaction analyses, to identify variants that modify the risk of PAD by diabetic or smoking status. Results: We identified 5 genome-wide significant ( P association ≤5×10 −8 ) associations with PAD in 449 548 (N cases =12 086) individuals of European ancestry near LPA (lipoprotein [a]), CDKN2BAS1 (CDKN2B antisense RNA 1), SH2B3 (SH2B adaptor protein 3) - PTPN11 (protein tyrosine phosphatase non-receptor type 11), HDAC9 (histone deacetylase 9), and CHRNA3 (cholinergic receptor nicotinic alpha 3 subunit ) loci (which overlapped previously reported associations). Meta-analysis with variants previously associated with PAD showed that 18 of 19 published variants remained genome-wide significant. In individuals with diabetes, rs116405693 at the CCSER1 (coiled-coil serine rich protein 1 ) locus was associated with PAD (odds ratio [95% CI], 1.51 [1.32–1.74], P diabetes =2.5×10 −9 , P interactionwithdiabetes =5.3×10 −7 ). Furthermore, in smokers, rs12910984 at the CHRNA3 locus was associated with PAD (odds ratio [95% CI], 1.15 [1.11–1.19], P smokers =9.3×10 −10 , P interactionwithsmoking =3.9×10 −5 ). Conclusions: Our analyses confirm the published genetic associations with PAD and identify novel variants that may influence susceptibility to PAD in the context of diabetes or smoking status.
Two-stage reimplantation for deep infection after total elbow arthroplasty
Martínez‐Catalán, Natalia , Nguyen, Ngoc Tram V. , O’Driscoll, Shawn W. , Sánchez‐Sotelo, Joaquín , O'Driscoll, Shawn W., Sanchez-Sotelo, J. , Fitzsimmons, James S , Morrey, Mark E.

Mayo Clinic

Shoulder & Elbow | October 4, 2021 | Volume: 14 | Issue: 6 | Pages: 668-676

10.1177/17585732211043524 | PMID 36479006 Get It

Background Persistent infection rate after 2-stage reimplantation complicating elbow arthroplasty has been reported to be as high as 25%. The purposes of this retrospective study were to determine the infection eradication rates, complications and outcomes in a cohort of patients treated with two-stage reimplantation for deep periprosthetic joint infection (PJI) following total elbow arthroplasty (TEA) and to determine possible associated risk factors for treatment failure. Methods Between 2000 and 2017, 52 elbows underwent a two-stage reimplantation for PJI after TEA. There were 22 males and 30 females with a mean age of 61 (range, 25–82) years. The most common bacterium was Staphylococcus epidermidis (28 elbows). Mayo Elbow Performance Scores were calculated at the latest follow-up. Mean follow-up time was 6 years (range, 2–14 years). Results PJI was eradicated in 36 elbows (69%). The remaining 16 elbows were considered treatment failures secondary to recurrent infection. The risk of persistent infection was 3.3 times higher in elbows with retained cement (p 0.04), and 3.5 times higher when the infecting organism was Staphylococcus epidermidis (p 0.06). Conclusion Two-stage reimplantation for PJI after TEA was successful in eradicating deep infection in 69% of cases. The eradication of PJI after TEA still needs to be improved substantially.
Clinical Challenges with Penile Prosthesis Placement and Peyronie’s Disease
Ziegelmann, Matthew , Habashy, Engy, Ziegelmann, Matthew J

Mayo Clinic

The Journal of Sexual Medicine | October 4, 2021 | Volume: 18 | Issue: 11 | Pages: 1822-1825

10.1016/j.jsxm.2021.08.011 | PMID 34610893 Get It